Atrial Fibrillation Ablation
12
3
4
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 12 trials
100.0%
+13.4% vs benchmark
8%
1 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 4 completed trials
Clinical Trials (12)
Catheter Ablation vs Conservative Care in Elderly Patients With Atrial Fibrillation
Association Between Circulating BDNF Levels and Atrial Cardiomyopathy in Patients Undergoing Ablation for Persistent Atrial Fibrillation
Tirzepatide to Reduce rEcurrence And Burden After Ablation of Atrial Fibrillation
Pulsed Field Ablation Outcomes With Efficacy and Randomization in Atrial Fibrillation (POWER-AF)
Comparative Intra-procedural Evaluation of Farapulse and FARAWAVE Nav Catheters
Impact of Catheter Stability on the Outcomes With Very High Power Short Duration Ablation
SUbstrate Ablation in Persistent Atrial Fibrillation for Elimination of Recurrences (SUPAFER).
Oesophageal Pacing to Check Left Atrial Posterior Wall Isolation
Vitamin C in Atrial Fibrillation Ablation
Comparison of Pulmonary Vein Isolation Using SmartTouch® Catheter With or Without Real-time Contact Force Data
Efficacy Study for Surgery After Previous Failed Catheter Ablation
A Prospective Randomized Study Comparing Radiofrequency Energy With Cryoenergy